Page last updated: 2024-12-05

metolcarb

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

metolcarb: pesticide; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID14322
CHEMBL ID2046816
CHEBI ID38537
SCHEMBL ID118244
MeSH IDM0525986

Synonyms (75)

Synonym
drc 3341
m-cresyl ester of n-methylcarbamic acid
nsc91193
1129-41-5
tsumacide
wln: 1mvor c1
mtmc
m-tolyl methylcarbamate
metacrate
m-cresyl methylcarbamate
3-tolyl n-methylcarbamate
m-tolyl n-methylcarbamate
m-cresyl n-methylcarbamate
nsc-91193
3-methylphenyl methylcarbamate
tumacide
carbamic acid, 3-tolyl ester
m-methylphenyl methylcarbamate
3-tolyl methylcarbamate
3-methylphenyl n-methylcarbamate
NCIOPEN2_001532
rcra waste no. p190
metholcarb
metolcarb [bsi:iso]
m-tolylester kyseliny methylkarbaminove [czech]
brn 2045865
nsc 91193
tsumaunka
kumiai
hsdb 6416
ai3-27694
s 1065
metholcarb [iso-french]
einecs 214-446-0
metolcarb
dicresyl n-methylcarbamate
CHEBI:38537 ,
methylcarbamic acid m-tolyl ester
carbamic acid, methyl-, 3-methylphenyl ester
carbamic acid, methyl-, m-tolyl ester
IDI1_012083
NCGC00160533-01
MAYBRIDGE3_000696
SR-01000641987-1
HMS1432P14
(3-methylphenyl) n-methylcarbamate
inchi=1/c9h11no2/c1-7-4-3-5-8(6-7)12-9(11)10-2/h3-6h,1-2h3,(h,10,11)
voeyxmafndnned-uhfffaoysa-
C18747
m-tolylmethylcarbamate
4-06-00-02050 (beilstein handbook reference)
3-methylphenyl-n-methyl carbamate
carbamic acid, n-methyl-, 3-methylphenyl ester
m-tolylester kyseliny methylkarbaminove
unii-4n7omz879v
4n7omz879v ,
AKOS006229276
CCG-52777
FT-0603547
CHEMBL2046816
metolcarb [iso]
metolcarb [hsdb]
SCHEMBL118244
DTXSID8057938
bdbm50004687
VOEYXMAFNDNNED-UHFFFAOYSA-N
carbamic acid, methyl-, 3-tolyl ester
metolcarb, pestanal(r), analytical standard
metolcarb 10 microg/ml in cyclohexane
mfcd00053076
HY-131126
AS-16081
Q6824213
CS-0129027
A907388

Research Excerpts

Compound-Compound Interactions

ExcerptReferenceRelevance
"In this work, we presented a three-dimensional (3D) molecularly imprinted electrochemical sensor (MIECS) with novel strategy for ultrasensitive and specific quantification of metolcarb based on prussian blue (PB) mediated amplification combined with signal enhancement of ordered mesoporous carbon."( Prussian blue mediated amplification combined with signal enhancement of ordered mesoporous carbon for ultrasensitive and specific quantification of metolcarb by a three-dimensional molecularly imprinted electrochemical sensor.
Cao, Y; Fang, G; Wang, S; Wang, X; Yang, Y, 2015
)
0.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
EC 3.1.1.7 (acetylcholinesterase) inhibitorAn EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of enzyme acetylcholinesterase (EC 3.1.1.7), which helps breaking down of acetylcholine into choline and acetic acid.
carbamate insecticideDerivatives of carbamic acid with insecticidal properties of general formula ROC(=O)NR(1)R(2), where ROH is an alcohol, oxime, or phenol and R(1) is hydrogen or methyl. Like organophosphate insecticides, they are cholinesterase inhibitors, but carbamate insecticides differ in action from the organophosphates in that the inhibitory effect on cholinesterase is generally brief.
acaricideA substance used to destroy pests of the subclass Acari (mites and ticks).
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
carbamate esterAny ester of carbamic acid or its N-substituted derivatives.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1081843In vivo insecticidal activity against apterous adult stage of Lipaphis erysimi (mustard aphids) in chinese cabbage leaves assessed as mortality at 300 mg/l at 25 degC treated for 10 secs measured after 24 hr2010Journal of agricultural and food chemistry, Dec-22, Volume: 58, Issue:24
Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.
AID671041Selectivity ratio of Ki for Anopheles gambiae AChE to Ki for human recombinant AChE2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID671040Inhibition of human recombinant AChE after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID671043Toxicity in anesthetized Anopheles gambiae G3 assessed as mortality treated as topical application assessed per mosquito after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID671042Toxicity in Anopheles gambiae G3 assessed as mortality treated as tarsal contact using dried filter papers after 24 hrs2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
AID1134599CHCl3-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID1081846Dual-site binding inhibition of AChE in Musca domestica (house fly) brain2010Journal of agricultural and food chemistry, Dec-22, Volume: 58, Issue:24
Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.
AID1134600Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Aug, Volume: 20, Issue:8
Hydrogen-bonding parameter and its significance in quantitative structure--activity studies.
AID671039Inhibition of Anopheles gambiae AChE expressed in Escherichia coli after 6 mins by Ellman assay2012Bioorganic & medicinal chemistry letters, Jul-15, Volume: 22, Issue:14
Re-engineering aryl methylcarbamates to confer high selectivity for inhibition of Anopheles gambiae versus human acetylcholinesterase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (15.00)18.7374
1990's1 (5.00)18.2507
2000's4 (20.00)29.6817
2010's10 (50.00)24.3611
2020's2 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.65

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.65 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index5.33 (4.65)
Search Engine Demand Index34.37 (26.88)
Search Engine Supply Index3.00 (0.95)

This Compound (23.65)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies2 (9.09%)4.05%
Observational0 (0.00%)0.25%
Other20 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]